Cidara Therapeutics logo

Cidara Therapeutics

Cidara (NASDAQ: CDTX) is developing long-acting therapeutics to improve the standard of care for patients facing serious diseases. The Company’s portfolio is comprised of new approaches aimed at transforming existing treatment and prevention paradigms, first with its lead Phase 3 antifungal candidate, rezafungin, in addition to drug-Fc conjugates (DFCs) targeting viral and oncology diseases from Cidara’s proprietary Cloudbreak® platform. Cidara is headquartered in San Diego, California.

Free account • No credit card • 5 profiles/day

Biotechnology 48 Employees Found San Diego, United States Founded 2013 2583 Similar Companies
48 Employees Found
93% Email Coverage
$5.0M Est Revenue
1 Office HQ
2583 Similar Companies

Frequently asked questions about Cidara Therapeutics

What is Cidara Therapeutics email format?

The widely used Cidara Therapeutics email format is {first_initial}{last} (e.g. jsmith@cidara.com) with 75.00% adoption across the company.

What is Cidara Therapeutics customer service number?

To contact Cidara Therapeutics customer service number in your country click here to find.

Who is the CEO of Cidara Therapeutics?

Jeff Stein is the CEO of Cidara Therapeutics. To contact Jeff Stein email at jeff.l.stein@gmail.com or jstein@cidara.com.